MINDRANK AI
MindRank (www.mindrank.ai) is an AI-driven biotech company with focus on “Undruggable” targets. The company started operations in 2021 and now consists of 35 scientists with R&D center in China and UK. The company is led by academicians of the British Royal Society, former R&D scientists from top pharma companies and the global AI competition winners. The team has successful experience in drug R&D and have a large number top publications including Nature Biomedical Engineering, Nature Mach... ine Intelligence, Patterns (Cell Press) etc. By leveraging its proprietary AI driven drug discovery platform, MindRank has delivered a small molecule Preclinical Candidate (allosteric inhibitor) to a listed biotechnology company in Sept 2021. In Jan 2022, MindRank begins IND-enabling studies of its proprietary AI-designed drug (Class B GPCR), 8 months after program initiation. Both of the small molecule drugs are expected to enter clinical phase in 2022.
MINDRANK AI
Social Links:
Industry:
Artificial Intelligence Biotechnology Health Care Pharmaceutical
Founded:
2020-12-23
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.mindrank.ai
Total Employee:
11+
Status:
Active
Contact:
+86 13761764536
Email Addresses:
[email protected]
Total Funding:
26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Euro Amazon Google Apps For Business
Similar Organizations
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Navina
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
Green Pine Capital Partners
Green Pine Capital Partners investment in Series A - MindRank AI
Huagai Capital
Huagai Capital investment in Series A - MindRank AI
Sherpa Venture Capital
Sherpa Venture Capital investment in Series A - MindRank AI
Sherpa Venture Capital
Sherpa Venture Capital investment in Seed Round - MindRank AI
Official Site Inspections
http://www.mindrank.ai
- Host name: ec2-122-248-229-52.ap-southeast-1.compute.amazonaws.com
- IP address: 122.248.229.52
- Location: Ulu Bedok Singapore
- Latitude: 1.3223
- Longitude: 103.9439
- Timezone: Asia/Singapore
- Postal: 46
More informations about "MindRank AI"
MindRank
Our AI-designed proprietary drug MDR-001, an oral small-molecule GLP-1 RA, obtained US IND approval in 19 months since program initiation, for the treatment of obesity and type 2 diabetes …See details»
MindRank AI - Crunchbase Company Profile & Funding
MindRank is an artificial intelligence (AI)-empowered drug discovery company. By leveraging its proprietary AI platforms (PharmKG, Molecule Dance and Molecule Pro), the company aims to …See details»
About Us - MindRank
Mindrank's AI-designed proprietary molecular glue drug candidate MRANK-103 began IND-enabling studies. Sep. Fortune China IMPACT. Oct. Completed the dosing of first cohort in Phase IIb study of MDR-001. 2025. Mar. US IND …See details»
MindRank AI - LinkedIn
MindRank (www.mindrank.ai) is an AI-driven biotech company with focus on “Undruggable” targets. The company started operations in 2021 and now consists of 35 scientists with R&D center in ...See details»
MindRank 2025 Company Profile: Valuation, Funding
Developer of an artificial intelligence (AI)--empowered drug discovery company intended to accelerate the drug discovery process and deliver small molecule medicines with differentiation and clinical benefits. ... www.mindrank.ai. …See details»
MindRank AI - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 18, 2023: Series A - …See details»
MindRank - Products, Competitors, Financials, Employees, …
MindRank is an AI-driven biotech company specializing in the discovery of small molecule drugs for challenging targets within the pharmaceutical industry. The company's main offerings …See details»
MindRank AI - Org Chart, Teams, Culture & Jobs - The Org
MindRank is a developer of an AI-enabled drug-discovery platform intended to discover and develop next generation precision medicines. Industries. AI/ML, Biotechnology +2. …See details»
MindRank AI - VentureRadar
MindRank AI is a developer of proprietary end-to-end AI driven drug-discovery platform, focusing on innovative pipeline and difficult-to-drug targets. It has three proprietary technology …See details»
MindRank AI - Company Profile & Staff Directory - ContactOut
MindRank (www.mindrank.ai) is an AI-driven biotech company with focus on “Undruggable” targets. The company started operations in 2021 and now consists of 35 scientists with R&D …See details»
Zhangming Niu - Founder & CEO @ MindRank AI
Primary Organization . MindRank AI . Location London, England, United Kingdom; Regions Europe, Middle East, and Africa (EMEA) Gender Male; LinkedIn View on LinkedIn ; Jobs. Edit Jobs Section. Number of Current Jobs …See details»
MindRank AI - Company profile | ensun
MindRank is a clinical stage AI-powered drug discovery company. MindRank has successfully delivered an allosteric inhibitor PCC with Best-in-Class potential to a public traded biotech …See details»
MindRank Ltd Secures Over $20 Million in Series A+ Funding to …
Jul 19, 2023 China-based artificial intelligence (AI)-enabled drug developer MindRank Ltd has reportedly secured more than USD 20 million in a Series A+ financing round. Cherami Investment led the investment, which will be utilized to enhance drug development efforts and to upgrade and commercialize the company's AI drug development platform.See details»
MindRank AI - Company info. interviews, news
MindRank AI is a developer of proprietary end-to-end AI driven drug-discovery platform, focusing on innovative pipeline and difficult-to-drug targets. It has three proprietary technology …See details»
MINDRANK TECHNOLOGIES LIMITED - Companies House
People for MINDRANK TECHNOLOGIES LIMITED (13590499) More for MINDRANK TECHNOLOGIES LIMITED (13590499) Registered office address Unit B2 Office New Smithfield Market, Whitworth Street East, Manchester, England, M11 2WJ ... MINDRANK AI EUROPE LTD. 07 Sep 2021 - 18 Oct 2021 MINDRANK EUROPE LIMITED ...See details»
ADMET Ranker
MindRank has independently developed an ADMET prediction software suite, offering offline, cloud-based, and API solutions. Leveraging a large language model (LLM)-powered data …See details»
MindRank - Company Profile - Tracxn
Dec 1, 2024 MindRank - Provider of AI-based drug candidate identification solutions for drug development. Raised a total funding of $30M over 3 rounds from 4 investors. Founded by Zhangming Niu in the year 2019. MindRank has 281 competitors.See details»
Nextsource | Company Profile | MindRank AI
Monitor if MindRank AI is shifting their marketing strategy based on recent ad campaigns or rebranding efforts. Find out if MindRank AI is undergoing leadership changes or executive …See details»
MindRank AI Overview | SignalHire Company Profile
Organization Website: mindrank.ai : MindRank AI industries Biotech: Headquarters Location: Shanghai, CN Shanghai, CN : MindRank AI Employees Size 10-50 employees: Founded: …See details»
AI-Driven Organizational Structure for Successful AI Transformation
Mar 28, 2025 Implementing an AI transformation demands rethinking traditional organizational structures. Successful AI teams require autonomy, flexibility, iterative practices, and extensive …See details»